Where does Organon's income statement data come from?

Every line is extracted from Organon's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Organon OGN Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$1.46B-3.1%	$1.51B-5.9%	$1.6B+0.5%	$1.59B+5.4%	$1.51B-5.0%
Total cost of revenue	$677M-11.6%	$766M+2.8%	$745M+3.5%	$720M+7.1%	$672M-3.4%
Gross profit	$783M+5.7%	$741M-13.5%	$857M-1.9%	$874M+3.9%	$841M-6.1%
Gross margin	53.6%+4.5pp	49.2%-4.3pp	53.5%-1.3pp	54.8%-0.8pp	55.6%-0.7pp
Research and development	$93M+2.2%	$91M+8.3%	$84M-11.6%	$95M-1.0%	$96M-26.2%
Selling, general and administrative	$424M-2.1%	$433M+4.3%	$415M-8.4%	$453M+7.9%	$420M-10.6%
Restructuring charges	$31M+343%	$7M—	$0-100%	$2M-97.7%	$86M+975%
Goodwill impairment	——	$301M—	——	——	——
Interest expense	$111M-8.3%	$121M-5.5%	$128M-2.3%	$131M+5.6%	$124M-6.1%
Other income (expense), net	-$7M-250%	-$2M+88.2%	-$17M-1,800%	$1M-75.0%	$4M+127%
Income before income taxes	$213M—	——	$243M+6.1%	$229M+127%	$101M-21.7%
Income tax expense	$67M+17.5%	$57M-31.3%	$83M-1.2%	$84M+500%	$14M—
Net income	$146M—	——	$160M+10.3%	$145M+66.7%	$87M-20.2%
Net margin	10%—	——	10%+0.9pp	9.1%+3.3pp	5.8%-1.1pp
Diluted earnings per share	$0.55—	——	$0.61+8.9%	$0.56+69.7%	$0.33-19.5%
Basic earnings per share	$0.56—	——	$0.61+8.9%	$0.56+64.7%	$0.34-19.0%
Weighted-average shares, diluted	262.9M+0.8%	260.8M0.0%	260.7M+0.2%	260.2M-0.3%	261M+0.7%
Weighted-average shares, basic	260.4M+0.3%	259.5M-0.2%	260M0.0%	259.9M+0.8%	257.9M+0.3%
Goodwill impairment losses	——	$301M—	——	——	——
Other Operating And Nonoperating Income (Expense)	$96M+45.5%	$66M+120%	$30M-14.3%	$35M+392%	-$12M0.0%
Acquired in-process research and development and milestones	$0—	$0—	$0—	$0-100%	$6M—
Research and development expense	$93M+2.2%	$91M+8.3%	$84M-11.6%	$95M-1.0%	$96M-26.2%
EBIT	$324M—	——	$371M+3.1%	$360M+60.0%	$225M-13.8%
EBITDA	$363M—	——	$411M+3.8%	$396M+52.9%	$259M-12.2%
EBITDA	$363M—	——	$411M+3.8%	$396M+52.9%	$259M-12.2%
EBITDA margin	24.9%—	——	25.7%+0.8pp	24.8%+7.7pp	17.1%-1.4pp
EBIT	$324M—	——	$371M+3.1%	$360M+60.0%	$225M-13.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Organon's income statement data come from?: Every line is extracted from Organon's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.